Can-Fite BioPharma Ltd. Recorded Big Gain
Mon, Dec 20, 2021 at 05:33 PM
Can-Fite BioPharma Ltd. (CANF:NYSEMKT) rocketted at $2.15, a gain of 69.3%. On Fri, Dec 17, 2021, CANF:NYSEMKT touched a New 2-Week High of $1.27. The stock appeared on our News Catalysts scanner on Mon, Dec 20, 2021 at 10:40 AM in the 'BIOTECH' category. From Fri, Dec 03, 2021, the stock recorded 50.00% Up Days and 45.45% Green Days
About Can-Fite BioPharma Ltd. (CANF:NYSEMKT)
Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases.
Top 10 Gainers:
- SOPA (SOPA:NASDAQ), 240.18%
- NHIC (NHIC:NASDAQ), 100%
- Bluerock Residential Growth REIT, Inc. (BRG:NYSEMKT), 76.17%
- Can-Fite BioPharma Ltd. (CANF:NYSEMKT), 69.29%
- SeaChange International, Inc. (SEAC:NASDAQ), 36.36%
- Verso Corporation (VRS:NYSE), 34.86%
- AERC (AERC:NASDAQ), 33.69%
- HLTH (HLTH:NASDAQ), 28.88%
- Galera Therapeutics, Inc. (GRTX:NASDAQ), 28.04%
- BioDelivery Sciences International, Inc. (BDSI:NASDAQ), 26.92%